Management skin manifestation of multisystem inflammatory syndrome associated with SARS-CoV-2

Table 2 The patient laboratory findings

Days	CRP mg/L	Ferritin ng/mL	D-dimer ng/mL	AST IU/L	ALT IU/L	Neut %	Lymph%	WBC cell/uL	Procal g/mL	Plt cell/uL
Day-0	48	466	2033	96	149	82.3	12.3	6	0.24	126
Trx-1	141	3978	1880	110	94	82.7	12.2	7.7	2.35	78
Trx -3	79	3419	964	162	155	82.2	14.2	11.7	0.85	167
Trx -5	29	1079	1120	121	197	54.8	36.3	7.3	0.21	288
Disch	3.2	424	435	404	663	65.2	55.2	5.2	0.065	265
Post-Op	1.3		400	27	31	46.8	40.6	4.3		253

Day 0 means the admission of the patient to the adult covid-19 service from the ER. IVIG and steroid treatment was given on day 1 (trx-1), day 3 (trx-3), day 5 (trx-5). The patient was discharged (Disch) on the day of the 14th, and the patient was seen day 18 (post-op) after the discharge. Neutrophil (Neut); Lymphocyte (Lymph); WBC (White blood cells); Procalcitonin (Procal); Platelet (Plt)

ISSN: 1743-422X